Invention Grant
- Patent Title: Compositions and methods for treating haematological proliferative disorders of myeloid origin
- Patent Title (中): 用于治疗骨髓源性血液增生性疾病的组合物和方法
-
Application No.: US13764492Application Date: 2013-02-11
-
Publication No.: US08715619B2Publication Date: 2014-05-06
- Inventor: Holger Karsunky
- Applicant: Cellerant Therapeutics, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Cellerant Therapeutics, Inc.
- Current Assignee: Cellerant Therapeutics, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K51/00
- IPC: A61K51/00 ; A61K39/00 ; A61K39/395 ; A61K38/00 ; G01N33/00
Abstract:
The disclosure relates to methods and compositions effective in the diagnosis, prognosis and treatment of human hematopoietic cancers. In particular, the disclosure provides tumor-associated genes that encode for cytokine receptors that are differentially expressed in hematopoietic tumor cells of myeloid origin compared with other cells, e.g., normal stem cells.
Public/Granted literature
- US20130216558A1 COMPOSITIONS AND METHODS FOR TREATING HAEMATOLOGICAL PROLIFERATIVE DISORDERS OF MYELOID ORIGIN Public/Granted day:2013-08-22
Information query
